NHSBT COVID-19 convalescent plasma collection is for a major coronavirus treatment trial, and if the trial is successful, widespread use in hospitals.
Convalescent plasma is the antibody-rich plasma of people who have recovered from COVID-19, which can be transfused into people with COVID-19 who are struggling to develop their own immune response.